News & media

Press Room & Corporate Updates.

Stay updated on our latest clinical advancements, corporate growth strategies, institutional partnerships, events, and funding milestones.

Content feed

Latest Updates.

Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China

Virax Biolabs’ Q3 2026 Investor Presentation: Next-Generation Diagnostics for Chronic Inflammation and Immune Dysfunction

Virax Biolabs’ CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes

Virax Biolabs’ CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders